Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch 
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape 
Instagram Outage Disrupts Thousands of U.S. Users 
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns 
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge 
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing 
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million 
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns 
Washington Post Publisher Will Lewis Steps Down After Layoffs 
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks 
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine 
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains 
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates 
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026 
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate 
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off 
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports 
Dublin, Oct. 24, 2017 -- The "Global Regenerative Medicines Market" report has been added to Research and Markets' offering.
Regenerative medicine is a branch of medicine involved with the repair or replacement of damaged tissues or organs. The field uses various strategies like the cell therapy, gene therapy and tissue engineering among others to replace the missing or damaged tissue or organ.
These also include the implantable medical devices. Regenerative medicine offers a treatment option for the incurable diseases such as cardiac diseases, immune-oncology and orphan diseases among others.
The gene therapy involves modulation of the target gene. It involves either the replacement, modification, silencing or introduction of the desired gene into the patient's body. Gene therapy may be done in vivo, where the gene is transferred to cells inside the body.
It may also be done ex vivo where the gene is incorporated into the cells outside the body which are then transferred into the patient's body. Cell therapy involves the administration of living non genetically modified cells into the patient's body. These cells multiply to replace or repair the damaged organ or tissue.
The cells used could be allogenic or autogenic. Tissue engineering technique involves biomaterials, biologically active molecules, cells, tissues or scaffolds.
Key Topics Covered:
Executive Summary
1 Report Scope
2 Market Overview
3 Market Dynamics
4 Competitive Insights
5 Industry Insights
- Regulatory Scenario
- Patent Landscape
6 Global Regenerative Medicine Market, By Therapy
- Cell Therapy
- Gene Therapy
- Tissue Engineering
7 Global Regenerative Medicine Market, by Product
8 Global Regenerative Medicine Market, By Application
- Orthopaedic
- Cardiology
- Wound Healing
- Diabetes
- Immuno-Oncology
- Others
9 Global Regenerative Medicine Market, By Geography
10 Company Profiles
- Acelity
- Athersys
- Cellular Biomedicine Group
- Cytori Therapeutics Inc.
- Integra LifeSciences
- Mesoblast
- MiMedx
- Novartis AG
- Nuvasive
- Organogenesis
- Osiris Therapeutics
- Stryker
- Terumo Corporation
- TiGenix
- Tissue Regenix
- Vericel Corporation
- Viacyte
- Zimmer Biomet
For more information about this report visit https://www.researchandmarkets.com/research/wsw6m5/global
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Biopharmaceuticals
